Riskpilot← Back to searchSign inGet full accessAULI APOTEK AS
ASActiveOrg 925614955Sentervegen 7, 1929 AuliRetail sale of pharmaceutical products · NACE 4773Est. 20205 employees
Revenue 2025
NOK 16,8M
-7% vs 2024
EBITDA margin
3.6%
-31% vs 2024
Equity ratio
34.8%
Financial strength
Net profit 2025
NOK 334K
-41% vs 2024
| Revenue | NOK 16,8M | -7% |
| EBITDA | NOK 602K | -31% |
| Net profit | NOK 334K | -41% |
| Total assets | NOK 3,4M | +3% |
| Equity | NOK 1,2M | -12% |
| Employees | 5 | — |
Legal name
AULI APOTEK AS
Org number
925614955
Legal form
Aksjeselskap
NACE code
4773 · Retail sale of pharmaceutical products
Founded
10. september 2020
Share capital
NOK 30 000
Employees
5 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styrets leder alene eller daglig leder alene.
Company purpose
Eie og drive apotek, herunder konsulenttjenester innenfor apotekerbransjen og lege- og helserelaterte produkter, samt øvrig virksomhet i tilknytning til dette
Address
Sentervegen 7, 1929 Auli
Phone
+4763885985
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 8 182 | 12 515 | 17 789 | 18 046 | 16 774 |
| Staff expenses | −670 | −1 729 | −1 568 | −1 973 | −2 190 |
| EBITDA | 809 | 695 | 1 613 | 877 | 602 |
| Depreciation & amort. | −107 | −96 | −86 | −135 | −165 |
| EBIT | 702 | 599 | 1 527 | 742 | 438 |
| Net financials | −74 | −27 | −0 | −7 | 5 |
| Profit before tax | 627 | 573 | 1 527 | 735 | 443 |
| Tax | 135 | 134 | 354 | 173 | 109 |
| Net profit | 492 | 439 | 1 173 | 562 | 334 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 3 222 | 3 085 | 6 937 | 3 343 | 3 446 |
| Equity | 508 | 130 | 803 | 1 365 | 1 199 |
| Long-term debt | 691 | 1 | 0 | 11 | 0 |
| Short-term debt | 2 023 | 2 954 | 6 133 | 1 967 | 2 238 |
| Total debt | 2 714 | 2 955 | 6 133 | 1 978 | 2 247 |
EBITDA margin
3.6%
This company
15.8%
Market median
-77% vs market
20212025
Equity ratio
34.8%
This company
38.2%
Market median
+9% vs market
20212025
Return on equity
27.9%
This company
18.4%
Market median
+52% vs market
20212025
Net profit margin
2.0%
This company
8.1%
Market median
-75% vs market
20212025
Asset turnover
4.87×
This company
1.12×
Market median
+335% vs market
20212025
Debt / equity
1.87×
This company
0.62×
Market median
-202% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AM Chief Executive Officer | Chief Executive Officer | 2020 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2020 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
A&H Holding As
AULI APOTEK AS Board members of AULI APOTEK AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Amir Mehmood | Chief Executive Officer | 0 companies |
| Herra Iqbal | Chairman | 0 companies |